The Asian Scientist 100
Tan Eng King
Institution
National Neuroscience Institute
Country
Singapore
Field
Life Sciences
Tan Eng King received the 2018 President’s Science Award for identifying clinical biomarkers, developing novel models and transforming patient care in Parkinson’s Disease. (Photo: National Neuroscience Institute)
Related articles
Priming The World For Primate Conservation (VIDEO)
As countries modernize, habitat destruction can threaten native primate species. Dr. Andie Ang believes that conservation efforts for primates can be strengthened with the right research.
Keeping Allergies Under Control (VIDEO)
Allergic reactions to peanuts can be dangerous, but Dr. Soh Jian Yi has devised an oral immunotherapy that can raise the tolerance level to peanuts in children.
Asia’s Rising Scientists: Ernest Chua
Wielding his expertise in mechanical engineering, Ernest Chua aims to develop innovations that can satisfy basic human needs without harming the environment.
Engendering Trust In An AI World
Regulators play a balancing act between protecting individuals and enabling business innovation, said speakers at a conference on AI and commercial law organised by SMU.
Speak Math, Not Code
Writing algorithms in mathematics rather than code is not only more elegant but also more efficient, says 2013 Turing Award winner Leslie Lamport.
The GDP Fudge: China Edition
By linking GDP growth to promotions, the Chinese government has inadvertently created incentives for provincial officials to report inaccurate financial data, a study says.
Asia’s Scientific Trailblazers: Marcelo Ang
One of Singapore’s robotics pioneers, Professor Marcelo Ang Jr’s research promises to take driverless cars and personal robotic assistants outside the realm of imagination and into the mainstream.
7 Best Practices From Singapore’s Pandemic Preparedness Playbook
Amid the COVID-19 outbreak, Singapore has won praise for its ‘gold standard’ response. Still, Singaporean medical leaders caution that several critical issues must first be addressed to quell the ongoing epidemic.
Advancing Antibody Research
Powerful antibody engineering technologies and a culture of collaboration set Chugai Pharmabody Research apart, says CEO Dr. Tomoyuki Igawa.